Expression and agonist responsiveness of CXCR3 variants in human T lymphocytes
- 24 January 2011
- journal article
- research article
- Published by Wiley in Immunology
- Vol. 132 (4), 503-515
- https://doi.org/10.1111/j.1365-2567.2010.03384.x
Abstract
The chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 are involved in variety of inflammatory disorders including multiple sclerosis, rheumatoid arthritis, psoriasis and sarcoidosis. Two alternatively spliced variants of the human CXCR3-A receptor have been described, termed CXCR3-B and CXCR3-alt. Human CXCR3-B binds CXCL9, CXCL10, CXCL11 as well as an additional ligand CXCL4. In contrast, CXCR3-alt only binds CXCL11. We report that CXCL4 induces intracellular calcium mobilization as well as Akt and p44/p42 extracellular signal-regulated kinase phosphorylation, in activated human T lymphocytes. These responses have similar concentration dependence and time-courses to those induced by established CXCR3 agonists. Moreover, phosphorylation of Akt and p44/p42 is inhibited by pertussis toxin, suggesting coupling to Gα(i) protein. Surprisingly, and in contrast with the other CXCR3 agonists, stimulation of T lymphocytes with CXCL4 failed to elicit migratory responses and did not lead to loss of surface CXCR3 expression. Taken together, our findings show that, although CXCL4 is coupled to downstream biochemical machinery, its role in T cells is probably distinct from that of CXCR3-A agonists.Keywords
This publication has 61 references indexed in Scilit:
- Multiple GPCR conformations and signalling pathways: implications for antagonist affinity estimatesTrends in Pharmacological Sciences, 2007
- Collateral efficacy in drug discovery: taking advantage of the good (allosteric) nature of 7TM receptorsTrends in Pharmacological Sciences, 2007
- Chemokines and their receptors as potential targets for the treatment of asthmaBritish Journal of Pharmacology, 2007
- CXCR3‐mediated T‐cell chemotaxis involves ZAP‐70 and is regulated by signalling through the T‐cell receptorImmunology, 2007
- GRKs and arrestins: regulators of migration and inflammationJournal of Leukocyte Biology, 2006
- A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor developmentThe Journal of Experimental Medicine, 2006
- Regulation of CXCR3 and CXCR4 expression during terminal differentiation of memory B cells into plasma cellsBlood, 2005
- The Role of Chemokine Receptors in Primary, Effector, and Memory Immune ResponsesAnnual Review of Immunology, 2000
- Lymphocyte-specific chemokine receptor CXCR3: regulation, chemokine binding and gene localizationEuropean Journal of Immunology, 1998
- G protein‐coupled receptor kinase 2 (GRK2): mechanisms of regulation and physiological functionsFEBS Letters, 1998